Related Experiment Video
Updated: Mar 22, 2026

09:09
Elevated Plus Maze for Mice
Published on: December 22, 2008
93.1K
Mice with Sort1 deficiency display normal cognition but elevated anxiety-like behavior
Chun-Sheng Ruan1, Chun-Rui Yang2, Jia-Yi Li1
1School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, SA 5000, Australia.
Experimental Neurology
|April 28, 2016
Summary
Sortilin, a pro-Brain-Derived Neurotrophic Factor (proBDNF) co-receptor, negatively regulates mood. Its absence alters behaviors, suggesting sortilin as a potential therapeutic target for mood disorders.
Area of Science:
- Neuroscience
- Molecular Psychiatry
- Behavioral Neuroscience
Background:
- Stressful life events contribute to mood disorders, but underlying mechanisms remain unclear.
- Brain-Derived Neurotrophic Factor (BDNF) influences mood, while its precursor (proBDNF) may have opposing effects.
- The roles of proBDNF co-receptors, P75(NTR) and sortilin, in mood regulation are largely unestablished.
Purpose of the Study:
- To investigate the role of sortilin in regulating mood-related behaviors in mice.
- To determine sortilin's involvement in proBDNF-mediated mood abnormalities.
Main Methods:
- Western blot analysis to quantify sortilin levels in stressed mice.
- Behavioral tests including open field, forced swimming, elevated plus maze, and Morris water maze.
- Assessment of mature BDNF and proBDNF levels in sortilin-deficient mice (in vivo and in vitro).
Main Results:
- Sortilin was upregulated in the neocortex and hippocampus of chronically stressed mice, correlating with decreased mobility and increased depression-like behavior.
- Sortilin deficiency led to hyperlocomotion and increased anxiety-like behavior but did not affect depression-like behavior or spatial cognition.
- ProBDNF administration induced depression-like behavior in both wild-type and sortilin-deficient mice, independent of sortilin levels.
Conclusions:
- Sortilin acts as a negative regulator of mood-related behaviors.
- Sortilin deficiency alters anxiety and locomotion but not depression or cognition.
- Sortilin represents a potential therapeutic target for mood disorder treatment.

